We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Vanderbilt University is 100th Facility to Install Genetix’ ClonePix FL
News

Vanderbilt University is 100th Facility to Install Genetix’ ClonePix FL

Vanderbilt University is 100th Facility to Install Genetix’ ClonePix FL
News

Vanderbilt University is 100th Facility to Install Genetix’ ClonePix FL

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Vanderbilt University is 100th Facility to Install Genetix’ ClonePix FL"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genetix announces that Vanderbilt Monoclonal Antibody Core (VMAC), Vanderbilt University, has become the 100th facility to purchase its ClonePix™ FL system.

Used for screening and selection of secretory cell lines, the ClonePix FL system can significantly reduce the time and costs associated with recombinant protein generation. VMAC will use the system to support its monoclonal and polyclonal antibody generation, purification, and characterization technical advice and services, and also its recombinant protein production and purification services.

Dr. Robert Carnahan, Director, VMAC, said: “Our aim at VMAC is to provide a centre of expertise in all areas of monoclonal antibody production and recombinant protein technology. It is vital that we are able to access state of the art technology such as the ClonePix FL system, in order to provide the best service for investigators both within Vanderbilt and beyond.”

Charles de Rohan, Head of the Genetix Business Unit within Leica Microsystems, commented: “We’re delighted that the benefits of ClonePix FL systems are recognized by so many laboratories. The VMAC is a highly prestigious institute and its decision to invest in this technology is testament to the value it brings to antibody and recombinant protein production.”
Advertisement